108 related articles for article (PubMed ID: 29038655)
1. Editorial: Induction of Central Nervous System Disease by the Adaptive Immune Response.
Weissert R; Brilot F
Front Immunol; 2017; 8():1218. PubMed ID: 29038655
[No Abstract] [Full Text] [Related]
2. Clinical features and long-term outcome of a group of Japanese children with inflammatory central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein antibodies.
Hino-Fukuyo N; Haginoya K; Nakashima I; Sato DK; Takahashi T; Misu T; Fujihara K; Hirose M; Kakisaka Y; Uematsu M; Kobayashi T; Kure S
Brain Dev; 2015 Oct; 37(9):849-52. PubMed ID: 25748628
[TBL] [Abstract][Full Text] [Related]
3. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
[TBL] [Abstract][Full Text] [Related]
4. Presentation of neuromyelitis optica spectrum disorder after more than twenty years of systemic sclerosis.
Hernández ZM; Cohen BA; Derwenskus J
Mult Scler Relat Disord; 2012 Oct; 1(4):202-3. PubMed ID: 25877268
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic criteria and differential diagnosis of neuromyelitis optica].
Nakashima I
Nihon Rinsho; 2014 Nov; 72(11):1964-9. PubMed ID: 25518378
[TBL] [Abstract][Full Text] [Related]
6. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.
Havla J; Kümpfel T; Schinner R; Spadaro M; Schuh E; Meinl E; Hohlfeld R; Outteryck O
J Neurol; 2017 Jan; 264(1):139-151. PubMed ID: 27844165
[TBL] [Abstract][Full Text] [Related]
7. Adaptive Immunity Is the Key to the Understanding of Autoimmune and Paraneoplastic Inflammatory Central Nervous System Disorders.
Weissert R
Front Immunol; 2017; 8():336. PubMed ID: 28386263
[TBL] [Abstract][Full Text] [Related]
8. Detection of Autoantibodies Against Myelin Oligodendrocyte Glycoprotein in Multiple Sclerosis and Related Diseases.
Spadaro M; Meinl E
Methods Mol Biol; 2016; 1304():99-104. PubMed ID: 25814289
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against aquaporin-4 and myelin oligodendrocyte glycoprotein in paediatric CNS demyelination: Recent developments and future directions.
Dale RC; Banwell B; Bar-Or A; Brilot F
Mult Scler Relat Disord; 2012 Jul; 1(3):116-22. PubMed ID: 25877076
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of neuromyelitis optica.
Wingerchuk DM; Lennon VA; Lucchinetti CF; Pittock SJ; Weinshenker BG
Lancet Neurol; 2007 Sep; 6(9):805-15. PubMed ID: 17706564
[TBL] [Abstract][Full Text] [Related]
11. Neuromyelitis optica-like pathology is dependent on type I interferon response.
Khorooshi R; Wlodarczyk A; Asgari N; Owens T
Exp Neurol; 2013 Sep; 247():744-7. PubMed ID: 23434493
[TBL] [Abstract][Full Text] [Related]
12. Novel advances in the diagnosis and treatment of neuromyelitis optica: is there a need to redefine the gold standard?
de Seze J; Collongues N
Expert Rev Clin Immunol; 2013 Oct; 9(10):979-86. PubMed ID: 24128159
[TBL] [Abstract][Full Text] [Related]
13. Periventricular white matter lesion and incomplete MRZ reaction in a male patient with anti-N-methyl-D-aspartate receptor encephalitis presenting with dysphoric mania.
Gahr M; Lauda F; Wigand ME; Connemann BJ; Rosenbohm A; Tumani H; Reindl M; Uzelac Z; Lewerenz J
BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25917068
[TBL] [Abstract][Full Text] [Related]
14. A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica.
Iyer A; Elsone L; Appleton R; Jacob A
Autoimmunity; 2014 May; 47(3):154-61. PubMed ID: 24512514
[TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
[TBL] [Abstract][Full Text] [Related]
16. Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.
Peschl P; Bradl M; Höftberger R; Berger T; Reindl M
Front Immunol; 2017; 8():529. PubMed ID: 28533781
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.
Hinson SR; Lennon VA; Pittock SJ
Handb Clin Neurol; 2016; 133():377-403. PubMed ID: 27112688
[TBL] [Abstract][Full Text] [Related]
18. Hypertrophic pachymeningitis accompanying neuromyelitis optica spectrum disorder: A case report.
Kon T; Nishijima H; Haga R; Funamizu Y; Ueno T; Arai A; Suzuki C; Nunomura J; Baba M; Takahashi T; Tomiyama M
J Neuroimmunol; 2015 Oct; 287():27-8. PubMed ID: 26439957
[TBL] [Abstract][Full Text] [Related]
19. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A
Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827
[TBL] [Abstract][Full Text] [Related]
20. Neuromyelitis optica.
Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
